Referencer:

1. Cutting KF,White RJ. Maceration of the skin and wound bed 1: its nature and causes. J Wound Care. 2002;7:275-278.

2. Pritchard D. Comparison of the performance characteristics of Versiva® XC™ against foam dressings. WHRI2720 AI127. November 22, 2006. Data on file, ConvaTec.

3. Walker M, Hobot JA, Newman GR, Bowler PG. Scanning electron microscopic examination of bacterial immobilisation in a carboxymethyl cellulose (AQUACEL®) and alginate dressings. Biomaterials. 2003;24:883-890.

4. Walker M, Cochrane CA. Protease sequestration studies: a comparison between AQUACEL® and Promogran® in their ability to sequester proteolytic enzymes. WHRI 2494 WA139. May 27, 2003. Data on file, ConvaTec.

5. Versiva® XC™ dressing [package insert]. Princeton, NJ: E.R. Squibb and Sons, L.L.C.; 2006.

6. Adams S. A new method to demonstrate intimate contact with a simulated wound bed of Versiva® XC™ dressings versus foam dressings. WHRI2938 TA111. December 11, 2006. Data on file, ConvaTec.

7. Griffiths B. Retention of fluid under compression of non-adhesive versions of Versiva® XC™ vs. Allevyn®, Biatain® and Mepilex®. WHRI2932 TA110. November 28, 2006. Data on file, ConvaTec.

8. Adams S. Fluid lateral spread in Versiva® XC™ dressings versus foam dressings. WHRI2927 TA107. November 24, 2006. Data on file, ConvaTec.

9. Griffiths B. Cushioning effects of various foam dressings and Versiva® XC™. WHRI2931 TA109. November 29, 2006. Data on file, ConvaTec.

10. A phase II non-comparative study on non-adhesive Versiva® XC™ on leg ulcers (N=46). CW-0501-04-U331. April 29, 2005. Data on file, ConvaTec.

11. Latham JN. A phase II, non-comparative safety and performance evaluation of Versiva® XC™ adhesive dressing in the management of pressure ulcers. CW-0501-04-AO78. February 14, 2006. Data on file, ConvaTec.

The reimbursement information provided by ConvaTec is intended to provide general informaiton revelant to coding and reimbursement of ConvaTec products only. Coverage and payment policies for the same insurer such as MediCare can vary from one region to another and may change from time to time because of on going changes in government and insurance industry rules and regulations.

Therefore, please check the DMERCS websites or other provider communications for any updates, to confirm use of appropite HCPCS Codes and to verify that billing is consistent with the particular insurers’s requirements. Since patient conditions and insurer requirements vary widely, ConvaTec cannot guarantee coverage or payment of its products.

AQUACEL, Hydrofiber, and Versiva are registered trademarks of E.R. Squibb & Sons, L.L.C. Betahesive, ConvaTec Wound Therapeutics, the Hydrofiber logo,
and XC are trademarks of E.R. Squibb & Sons, L.L.C. All other trademarks are the property of their respective owners.

©2007 E.R. Squibb & Sons, L.L.C. US-07-254